Apogee Therapeutics, Inc (NASDAQ:APGE) Signals Near-Term Upside Momentum Despite Overvalued Tag
Apogee trades with visible bullish momentum across multiple short-term indicators while the firm's balance sheet and valuation metrics frame the stock as over-valued by WMDST.









